GLP-1 Washout Period: How Long Before Trying to Conceive
If you are on a GLP-1 medication and planning pregnancy, understanding the washout period is one of the most important safety considerations. This guide provides medication-specific timelines, the science behind the recommendations, and practical strategies for the transition.
More on Women's Health
Critical Safety Information
All GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) are contraindicated during pregnancy. Animal studies have demonstrated potential adverse effects on fetal development. Do not attempt conception until the full washout period has elapsed. If you discover you are pregnant while on a GLP-1 medication, stop the medication immediately and contact your healthcare provider.
Washout Periods by Medication
Each GLP-1 medication has a different half-life, which determines how long the drug remains active in your body after the last dose. The washout recommendation is typically 5 or more half-lives, plus a safety margin.
Semaglutide (Ozempic, Wegovy, Rybelsus)
Half-life
~7 days
Time to clear (~5 half-lives)
~5 weeks
Recommended washout
At least 2 months
The 2-month recommendation per the prescribing information provides a safety margin beyond pharmacological clearance. This is the most widely cited and conservative guideline.
Tirzepatide (Mounjaro, Zepbound)
Half-life
~5 days
Time to clear (~5 half-lives)
~3.5 weeks
Recommended washout
At least 1 month*
*The prescribing information recommends at least 1 month. However, some reproductive endocrinologists recommend waiting 2 months for additional safety margin. Follow your specific provider's guidance.
Liraglutide (Saxenda, Victoza)
Half-life
~13 hours
Time to clear (~5 half-lives)
~3 days
Recommended washout
At least 2 months
Despite liraglutide's shorter half-life and rapid clearance, the prescribing information still recommends a 2-month washout before conception, reflecting the general precautionary approach for this drug class.
Understanding the Safety Rationale
The washout recommendations are based on the precautionary principle rather than documented human harm. Here is what the evidence shows:
Animal Study Findings
- - Reduced fetal growth at doses comparable to human therapeutic levels
- - Skeletal abnormalities observed in some animal models
- - Pregnancy loss at higher doses in some studies
- - Effects varied by species, dose, and timing of exposure
Human Data (Inadvertent Exposure)
- - Growing registry data from women who became pregnant on GLP-1s
- - Most reported cases have not shown clear signals of birth defects
- - Data is still limited and cannot definitively confirm safety
- - Reassuring trends but insufficient to change the recommendation
The bottom line is that while the absolute risk to a human pregnancy from brief early GLP-1 exposure appears to be low based on available data, the evidence is not sufficient to guarantee safety. The washout period eliminates this uncertainty entirely.
Planning Your Transition: A Step-by-Step Guide
Communicate Your Timeline
Tell your GLP-1 prescriber about your conception plans as early as possible. They can help plan your treatment course to maximize weight loss before the planned stop date. If working with a fertility specialist, coordinate both providers so everyone is aligned on timing.
Prepare for the Stop
In the 2-4 weeks before stopping, focus on strengthening the habits that will sustain your weight: meal prep routines, exercise consistency, adequate protein intake. Consider working with a registered dietitian to create a specific post-medication nutrition plan.
Stop the Medication
Some clinicians taper the dose before stopping; others have patients stop at their current dose. Both approaches are acceptable. Mark your calendar for the washout end date (2 months for semaglutide, 1-2 months for tirzepatide).
Start Prenatal Preparation
Begin prenatal vitamins immediately (if not already taking them). Key nutrients: folate (at least 800 mcg, ideally methylfolate), vitamin D (2000-4000 IU), omega-3 DHA, iron, and iodine. These should be started before conception, not after.
Continue Contraception During Washout
Use reliable contraception throughout the washout period. Do not attempt conception until the full washout time has passed, even though the medication may be largely cleared before then.
Begin Trying to Conceive
After the full washout period, you can safely begin trying to conceive or proceed with fertility treatments like IVF. The metabolic improvements from your weight loss will continue to benefit your fertility and pregnancy health.
What If You Get Pregnant Unexpectedly
Despite best planning, unplanned pregnancies happen, especially because GLP-1 medications can restore fertility in previously anovulatory women. If you discover you are pregnant while on a GLP-1 medication or during the early washout period:
Stop the GLP-1 medication immediately if you have not already
Contact your healthcare provider right away to discuss next steps
Start prenatal vitamins immediately if not already taking them
Schedule early prenatal care for appropriate monitoring
Do not panic: most inadvertent early exposures in human registries have shown reassuring outcomes
Your healthcare provider may recommend additional early ultrasound monitoring and possibly referral to a maternal-fetal medicine specialist depending on the timing and duration of exposure. The most important steps are stopping the medication promptly and seeking early prenatal care.
After Pregnancy: When Can You Resume?
Many women want to resume GLP-1 therapy after pregnancy to manage weight. The timeline depends on your postpartum situation:
If Not Breastfeeding
GLP-1 medications can generally be restarted once you are medically stable postpartum, typically 4-6 weeks after delivery. Your provider will evaluate your recovery and readiness. Treatment restarts at the initial low dose with standard titration.
If Breastfeeding
GLP-1 medications are not recommended during breastfeeding due to unknown effects on the infant through breast milk. Wait until breastfeeding is completed or discuss with your provider about the timing of weaning and medication restart. See our guide on breastfeeding after GLP-1.
Frequently Asked Questions
Why do I need to stop GLP-1 medications before trying to conceive?
GLP-1 medications are classified as contraindicated during pregnancy based on animal studies showing adverse effects on fetal development, including reduced fetal growth and skeletal abnormalities. While limited human data from inadvertent exposures has not shown clear signals of harm, the precautionary principle applies. The washout period ensures the medication is fully cleared from your system before conception occurs, eliminating any potential fetal exposure.
What is the washout period for semaglutide (Ozempic/Wegovy)?
The recommended washout period for semaglutide is at least 2 months (8 weeks) before attempting conception. Semaglutide has a half-life of approximately 7 days, meaning it takes about 5 weeks for the medication to be essentially cleared from the body. The 2-month recommendation provides an additional safety margin beyond pharmacological clearance.
What is the washout period for tirzepatide (Mounjaro/Zepbound)?
The recommended washout period for tirzepatide is at least 1 month (4 weeks) before attempting conception. Tirzepatide has a half-life of approximately 5 days. However, some reproductive endocrinologists recommend waiting 2 months for additional safety margin, similar to semaglutide. Follow your specific provider's recommendation.
What happens if I get pregnant during the washout period?
If you discover you are pregnant during the washout period (after already stopping the medication), contact your healthcare provider immediately but do not panic. The medication levels will be declining or already undetectable depending on how far into the washout you are. Report the timing of your last injection so your provider can estimate potential exposure level. Current data from pregnancy registries has not shown clear evidence of harm from early inadvertent exposure, but additional monitoring may be recommended.
Can I use contraception during the washout period?
During the washout period, you should continue using contraception until the full recommended washout time has passed. If you are using oral contraceptives, your menstrual cycles should normalize after stopping both the GLP-1 medication and birth control before timing conception. If using non-hormonal contraception (condoms, diaphragm), you can stop contraception once the washout period is complete.
Will I gain weight during the washout period?
Modest weight regain is possible during the washout period as appetite may gradually increase without medication support. However, the 1-2 month washout period is relatively short, and most women can maintain their weight through continued lifestyle strategies. Focus on high protein intake (1.4-1.6 g/kg/day), resistance training, structured meal planning, and adequate sleep. Most women experience minimal regain (0-5 lbs) during a properly managed 2-month washout.
Planning for Pregnancy After GLP-1 Therapy?
Our medical team can help you create a safe transition plan that protects your health goals and your future pregnancy.
Plan Your TransitionMedical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).